Home » Topics » Regulatory

Regulatory
RSS

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Synergism reported by Aventis for combination chemotherapies

July 27, 2000

SmithKline Beecham submits sNDA for Paxil for use in PTSD

July 25, 2000

Fibrate/statin combinations claimed in recent patent literature by Bayer

July 24, 2000

Neuroprotective effects described for SB-269970

July 24, 2000

U.K. launch announced for Zyban

July 24, 2000

First regulatory approval obtained for Migard

July 21, 2000

Zambon and Sheffield submit IND for MSI-cromolyn

July 21, 2000

DepoMed's Metformin GR gives positive multiple-dose phase I results

July 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...